Summary
Overview
Work History
Education
Skills
Scientific Skills
Awards
Invited Talks
Publications
References
Volunteer Experience
Timeline
Generic

Monica (Jushchyshyn) Chu

Lansdale,PA

Summary

Extensive knowledge of LC-MS techniques including HRMS, QQQ, SWATH, IDA and EAD methods to analyze small molecules, PROTACs and proteins. Fluent in in vitro DMPK techniques including CYP DI/TDI, protein binding, metabolic stability, reaction phenotyping and SSID. Experienced with managing CRO activities. Hands on involvement with troubleshooting, maintaining, and repairing various laboratory instrumentation.

Overview

26
26
years of professional experience

Work History

Senior Scientist I

Exelixis
03.2023 - 01.2024
  • Established in vitro DMPK capabilities at the new Radnor, PA lab
  • Performed in vitro metabolic stability assays with human and preclinical species liver fractions including hepatocytes and liver microsomes
  • Developed work flow to analyze metabolic stability samples with LC-HRMS to both quantitate parent compound and qualitatively deduce SSID with one injection (Sciex 7600 QTOF) to support SAR optimization
  • Implemented Oniro Massmeta Site to streamline SSID
  • Implemented high throughput liquid handling technology to increase efficiency of in vitro assays (Echo, Assist Plus)
  • Oversaw China-based CRO activities including in vitro DMPK assay requests, compound shipment, data receipt and troubleshooting, report review
  • Played a critical role in IND-enabling protocol review and editing for in vitro assays to be performed at the CRO
  • Presented “chalk talks” to the department to highlight recent data, challenges and lessons learned.

Senior Scientist II

Frontage Laboratories
12.2021 - 03.2023
  • Performed in vitro DMPK assays including CYP DI/TDI, CYP reaction phenotyping, drug stability in biological matrices, plasma protein binding, CYP inactivation kinetics (KI, kinact)
  • Developed and validated CYP DI/TDI assay on automated liquid handling system (Tecan)
  • LC-MS method development to quantitate test article and metabolites
  • Completed full data analysis for the above assays and wrote summary reports for client
  • Reviewed, edited and finalized assay reports
  • Solved LC-MS analysis of analytically challenging compounds such as suramin
  • Authored and reviewed SOPs.

Adjunct Professor

Ursinus College
08.2012 - 12.2021
  • Instructed General Chemistry, Organic Chemistry and Forensics Chemistry laboratory courses
  • Presented instructional chemistry lectures to students
  • Mentored students in the laboratory: stressing good safety practices, standard record keeping and appropriate chemical techniques
  • Maintained office hours to meet with students and further assist them with their inquiries.

Postdoctoral Fellow

Department of Pharmacology and Toxicology, Virginia Commonwealth University
07.2008 - 07.2009
  • Investigations to determine the molecular mechanisms of morphine tolerance
  • Focused on devising a method to quantitate changes in phosphorylation of the mu-opioid receptor
  • Studied the effect of ethanol on morphine glucuronidation in mouse brain and liver microsomes.

Research Investigator

University of Michigan
09.2007 - 06.2008
  • Conducted in vitro P450 drug metabolism assays and preliminary hydrogen/deuterium exchange experiments to monitor P450 conformation in solution
  • Mentored and advised graduate students and laboratory technicians
  • Maintained laboratory equipment including HPLC and LC-MS instruments.

Clinical Assay Specialist (contractor)

Pfizer Inc.
07.2006 - 02.2007
  • Managed quantitative analysis of PK and biomarker samples in support of clinical trials
  • Reviewed bioanalytical summary reports and raw data including chromatograms, assay linearity, specificity, sensitivity, precision and accuracy for GLP and SOP compliance
  • Established and managed study budgets, payment agreements, and processed invoices related to bioanalytical projects.

Postdoctoral Fellow

Pharmacokinetics, Dynamics, & Metabolism, Pfizer
01.2004 - 01.2006
  • Demonstrated that cytochrome b5 directly induces atypical turnover kinetics of pyrene by P450 3A4
  • Used in vitro and biomimetic chemical systems to generate metabolites, reactive intermediates, and glutathione conjugates of P450 substrates.

Doctoral Candidate

Department of Pharmacology, University of Michigan
01.1998 - 01.2003
  • Fully characterized phencyclidine as a mechanism-based inactivator for P450 2B6 where covalent binding occurred on the apoprotein in a 1:1 (P450:PCP) stoichiometry
  • Identified PCP metabolites and a possible PCP-GSH conjugate formed during catalytic turnover
  • Proteolytically digested the PCP-inactivated P450 in an attempt to identify the PCP-labeled peptide by ESI-LC-MS/MS analysis.

Education

Ph.D. - Department of Pharmacology

University of Michigan
Ann Arbor, Michigan
01.2003

B.S. - Department of Chemistry

Ursinus College
Collegeville, Pennsylvania
01.1998

Skills

  • Training and mentoring
  • Scientific Writing
  • Safety processes and procedures
  • Research and experiments
  • Experimental design
  • Drug Discovery
  • Technical Presentations
  • Workflow optimization
  • Data and document review/editing
  • Research and publication
  • Self-Driven and Motivated
  • Equipment Maintenance

Scientific Skills

Qualitative and quantitative LC-MS/MS (Sciex 4000 through 6500 and QTOF 7600, ThermoQuest LC-Q, Deca, TSQ), HPLC (Waters, Agilent, Shimadzu), spectrophotometry, fluorophotometry, electrochemistry, P450 kinetics, metabolite identification, solid phase extraction, Fenton chemistry, SDS-PAGE, Western blot analysis, immunoprecipitation of proteins, proteolytic digestion of proteins, protein expression and purification, protein preparation from animal tissue. Liquid handling platforms such as Tecan, Integra Assist Plus, Echo. Fluent with Sciex OS and Analyst software (Sciex) and Microsoft Office. Proficient with Oniro Massmeta Site.

Awards

  • Pharmacological Sciences Training Program Fellowship recipient, 1998-2001.
  • Thomas Baum Travel Award, February 2001.
  • 62nd Intercollegiate Student Chemists Conference, 1st Place, Physical Chemistry, 1998.
  • National Science Foundation Research Experience for Undergraduates Fellowship, 1997.
  • Chemistry Merit Scholarship, Ursinus College, 1994-1998.

Invited Talks

  • Jushchyshyn, M.I.; Kent, U.M.; and Hollenberg, P.F. (2001) Electrospray liquid chromatography-mass spectrometry analysis of phencyclidine-inactivated human P450 2B6 and identification of a phencyclidine-adducted peptide. 20th Annual Graduate Student Symposium in the Pharmacological Sciences and Bio-related Chemistry, Ann Arbor, MI.
  • Hollenberg, P.F.; Jushchyshyn, M.I.; Chun, J.; Sayre, L.M.; and Kent, U.M. (2000) Metabolic inactivation of rat and human cytochromes P450 by phencyclidine. 219th American Chemical Society Meeting, San Francisco, CA.
  • Jushchyshyn, M.I.; Kent, U.M.; and Hollenberg, P.F. (1999) Mechanism-based inactivation of human P450 2B6 by phencyclidine. 28th Annual Pharmacology Research Colloquium, East Lansing, MI.

Publications

  • Lin HL, Zhang H, Jushchyshyn M, Hollenberg PF. (2010) Covalent modification of Thr302 in cytochrome P450 2B1 by the mechanism-based inactivator 4-tert-butylphenylacetylene. Journal of Pharmacology and Experimental Therapeutics 333: 663-669.
  • Jushchyshyn, M.I.; Wahlstrom, J.L.; Hollenberg, P.F.; Wienkers, L.C. (2006) Mechanism of Inactivation of Cytochrome P450 2B6 by Phencyclidine. Drug Metabolism and Disposition 34: 1523-1529.
  • Shebley, M.; Jushchyshyn, M.I.; Hollenberg, P.F. (2006) Selective Pathways for the Metabolism of Phencyclidine by Cytochrome P450 2B Enzymes: Identification of Electrophilic Metabolites, Glutathione and N-Acetylcysteine Adducts. Drug Metabolism and Disposition 34: 375-383.
  • Jushchyshyn, M.I.; Hutzler, J.M.; Schrag, M.L.; Wienkers, L.C. (2005) Catalytic Turnover of Pyrene by CYP3A4: Evidence that Cytochrome b5 Directly Induces Positive Cooperativity. Archives of Biochemistry and Biophysics 438: 21-28.
  • Jushchyshyn, M.I.; Kent, U.M.; and Hollenberg, P.F. (2003) The Mechanism-Based Inactivation of Human Cytochrome P450 2B6 by Phencyclidine and Investigations of the Identity of the Covalently Modified Peptide. Drug Metabolism and Disposition 31: 46-52.
  • Kent, U.M.; Jushchyshyn, M.I.; and Hollenberg, P.F. (2001) Mechanism-based Inactivators as Probes of Cytochrome P450 Structure and Function. (Review) Current Drug Metabolism 2: 215-243.

References

Available upon request

Volunteer Experience

  • Handler of a therapy certified dog, Chipper. We visit libraries, schools, and doctors’ offices.
  • Three years on the planning committee for the Bear2Bear emergency student fund at Ursinus College. Helped with planning all aspects of this annual fundraising event including obtaining sponsorships, program ads and auction items as well as bolstering faculty involvement.
  • Currently serving on the Major Gifts Committee at Ursinus College. Involved with communications to Ursinus community members to raise funds for annual giving.
  • Science Fair judge: Judged numerous student science fairs.

Timeline

Senior Scientist I

Exelixis
03.2023 - 01.2024

Senior Scientist II

Frontage Laboratories
12.2021 - 03.2023

Adjunct Professor

Ursinus College
08.2012 - 12.2021

Postdoctoral Fellow

Department of Pharmacology and Toxicology, Virginia Commonwealth University
07.2008 - 07.2009

Research Investigator

University of Michigan
09.2007 - 06.2008

Clinical Assay Specialist (contractor)

Pfizer Inc.
07.2006 - 02.2007

Postdoctoral Fellow

Pharmacokinetics, Dynamics, & Metabolism, Pfizer
01.2004 - 01.2006

Doctoral Candidate

Department of Pharmacology, University of Michigan
01.1998 - 01.2003

Ph.D. - Department of Pharmacology

University of Michigan

B.S. - Department of Chemistry

Ursinus College
Monica (Jushchyshyn) Chu